Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

Sakar Healthcare Regulatory Approval

Sakar Healthcare Limited received 14 oncology product approvals in the EU, UK, and Canada. These approvals for licensed-out products and site variations will drive top-line sales growth.

Source

NSE filing, NSE: SAKAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sakar Healthcare Ltd: key numbers

Share price
₹934.45
Market cap
₹2,079 Cr
Revenue (annual)
₹251.7 Cr
Net profit (annual)
₹30.48 Cr
P/E (TTM)
48.5×Sector 47.2×
Promoter holding
51.70%-0.82% QoQ
FII holding
12.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sakar Healthcare Ltd

All →

Other regulatory approval announcements

All →
11:28 IST NSE
Regulatory ApprovalGland Pharma Ltd GLAND

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

18:29 IST BSE
Regulatory ApprovalCity Union Bank Ltd CUB

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution
Three years from the date of taking charge
18:04 IST BSE
Regulatory ApprovalLupin Ltd LUPIN

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

19:01 IST NSE
Regulatory ApprovalSom Distilleries & Breweries Ltd SDBL

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.

12:15 IST NSE
Regulatory ApprovalAGI Infra Ltd AGIIL

AGI Infra Regulatory Approval

Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.

Execution
Valid up to March 30, 2031
11:08 IST BSE
Regulatory Approval360 One Wam Ltd 360ONE

360 One Wam Regulatory Approval

360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.